Education
About Us
Working with TipRanks
Follow Us
IPCA Laboratories Limited (IN:IPCALAB)
:IPCALAB
Total Valuation
IPCA Laboratories Limited has a market cap or net worth of ₹361.17B. The enterprise value is ₹396.88B.
Market Cap₹361.17B
Enterprise Value₹396.88B
Share Statistics
IPCA Laboratories Limited has 253,704,220 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding253,704,220
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IPCA Laboratories Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 19.44%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)19.44%
Return on Capital Employed (ROCE)0.34
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.69
Inventory Turnover1.15
Valuation Ratios
The current PE Ratio of IPCA Laboratories Limited is 57.52. IPCA Laboratories Limited’s PEG ratio is 3.57.
PE Ratio57.52
PS Ratio―
PB Ratio4.97
Price to Fair Value4.97
Price to FCF59.03
Price to Operating Cash Flow33.33
PEG Ratio3.57
Income Statement
In the last 12 months, IPCA Laboratories Limited had revenue of 76.22B and earned 5.47B in profits. Earnings per share was 21.57.
Revenue76.22B
Gross Profit47.75B
Operating Income29.60B
Pretax Income8.43B
Net Income5.47B
EBITDA13.30B
Earnings Per Share (EPS)21.57
Cash Flow
In the last 12 months, operating cash flow was 3.80B and capital expenditures 0.00, giving a free cash flow of 3.80B billion.
Operating Cash Flow3.80B
Free Cash Flow3.80B
Free Cash Flow per Share14.97
Dividends & Yields
IPCA Laboratories Limited pays an annual dividend of ₹2, resulting in a dividend yield of 0.28%
Dividend Per Share₹2
Dividend Yield0.28%
Payout Ratio6.28%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change9.42%
50-Day Moving Average1.41K
200-Day Moving Average1.45K
Relative Strength Index (RSI)52.83
Average Volume (3m)5.73K
Important Dates
IPCA Laboratories Limited upcoming earnings date is May 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 13, 2025
Next Earnings DateMay 28, 2025
Ex-Dividend DateNov 27, 2024
Financial Position
IPCA Laboratories Limited as a current ratio of 2.35, with Debt / Equity ratio of 17.94%
Current Ratio2.35
Quick Ratio1.30
Debt to Market Cap0.04
Net Debt to EBITDA0.92
Interest Coverage Ratio21.40
Taxes
In the past 12 months, IPCA Laboratories Limited has paid 3.13B in taxes.
Income Tax3.13B
Effective Tax Rate0.37
Enterprise Valuation
IPCA Laboratories Limited EV to EBITDA ratio is 24.60, with an EV/FCF ratio of 61.34.
EV to Sales4.29
EV to EBITDA24.60
EV to Free Cash Flow61.34
EV to Operating Cash Flow34.63
Balance Sheet
IPCA Laboratories Limited has ₹8.54B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹8.54B billion.
Cash & Marketable Securities₹8.54B
Total Debt₹0.00
Net Cash-₹8.54B
Net Cash Per Share-₹33.67
Tangible Book Value Per Share₹295.38
Margins
Gross margin is 61.95%, with operating margin of 38.83%, and net profit margin of 7.18%.
Gross Margin61.95%
Operating Margin38.83%
Pretax Margin11.06%
Net Profit Margin7.18%
EBITDA Margin17.45%
EBIT Margin12.86%
Analyst Forecast
The average price target for IPCA Laboratories Limited is ₹1,760.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,760.00
Price Target Upside32.27% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―